|A Research Program Committed to Improving the Understanding and Delivery of Cancer Medicine
At Stony Brook Cancer Center, we do not just deliver the most advanced cancer medicine, we also help develop it. As a research-based institution, we have devoted considerable resources to helping shape the study and practice of cancer medicine. Our goal is to get these innovations from the “bench to the bedside” as efficiently and safely as possible.
Today, we are studying the molecular mechanisms of hepatocellular carcinoma (liver cancer), the mechanisms behind tamoxifen-induced endometrial cancer, and much more. Learn about our basic cancer research efforts at our Clinical Research Center site.
At the Cancer Center, many of our doctors both deliver patient care and perform ongoing research. Not only does this give patients a pipeline to the latest treatments, but the emphasis also attracts the best physician-scientists from around the country, as well as additional funding.
Stony Brook is dedicated to basic and translational research as well as clinical trials. As a university-based program, our researchers have the opportunity to work collaboratively with other experts across the campus. For example, our biomedical researchers might work with our Institute of Chemical Biology and Drug Discovery as well as with the Department of Applied Mathematics and Statistics. In addition, a state-of-the-art Medical and Research Translation (MART) building is in the planning stages. It will house investigators and projects on cancer research, advanced imaging and new technologies to advance cancer care.
|A Focus on Personalized
At the heart of our cancer research is a drive to find more effective medicines and more highly targeted treatments. Our researchers are looking at better calibrating dosage and timing, exploring the genetic component to determine which patients are the best candidates for chemotherapy, developing less invasive diagnostic and screening methods, using molecular biology to create individualized cancer therapies, developing treatments that are just as effective in preserving a patient’s quality of life as they are in attacking cancer cells.